TrialTransfusion2025

SARS-CoV-2 convalescent plasma for the controlled clinical trial "COVIC-19": Experience from collection of very high-titer plasma from superimmunized individuals.

Simone Hoffmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.